According to Rani Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.38. In 2022 the company made an earnings per share (EPS) of -$1.28 a decrease over its 2021 EPS that were of -$0.43.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.38 | 7.81% |
2022 | -$1.28 | 197.67% |
2021 | -$0.43 | -0.08% |
2020 | -$0.43 |